Top

Clinical & Experimental Metastasis

Published in:

01-01-1998

Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential

Authors: Bing-Sen Zhou, Pamela Tsai, Rhonda Ker, Jeffrey Tsai, Roger Ho, Johnathan Yu, Jennifer Shih, Yun Yen

Published in: Clinical & Experimental Metastasis | Issue 1/1998

Title: Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential
Authors: Bing-Sen Zhou
Pamela Tsai
Rhonda Ker
Jeffrey Tsai
Roger Ho
Johnathan Yu
Jennifer Shih
Yun Yen
Publication date: 01-01-1998
Publisher: Kluwer Academic Publishers
Published in: Clinical & Experimental Metastasis / Issue 1/1998
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI: https://doi.org/10.1023/A:1006559901771

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/1998

Endothelial cell intracellular Ca concentration is increased upon breast tumor cell contact and mediates tumor cell transendothelial migration

Hepatocyte growth factor stimulates the invasion of gallbladder carcinoma cell lines in vitro

Adhesion to fibronectin's EDbdomain induces tyrosine phosphorylation of focal adhesion proteins in Balb/c 3T3 cells

αv Integrins mediate adhesion and migration of breast carcinoma cell lines

Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonist

Over-expression of human CD44s in murine 3T3 cells: selection against during primary tumorigenesis and selection for during micrometastasis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer